DALE Pharma

Enghien ·KBO/BCE: BE 0791.839.803

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	19.6%	17.7%	better than 52% of 779 sector peers
Net result	€716	€12k	better than 36% of 775 sector peers
Equity	€606k	€80k	better than 83% of 780 sector peers
Gross operating margin	€1.30M	€164k	better than 95% of 701 sector peers
Staff costs	€1.20M	€191k	higher than 91% of 611 sector peers

Line item	Code	2023
Balance sheet, Assets
TOTAL ASSETS	20/58	€3.08M
Fixed assets	21/28	€338k
Formation expenses	20	€0
Intangible fixed assets	21	€192k
Tangible fixed assets	22/27	€146k
Financial fixed assets	28	€363
Current assets	29/58	€2.75M
Stocks & contracts in progress	3	€1.30M
Amounts receivable within one year	40/41	€1.41M
Investments	50/53	€0
Cash & bank	54/58	€34k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€3.08M
Equity	10/15	€606k
Contributions / capital	10/11	€605k
Accumulated profits (losses)	14	€716
Amounts payable	17/49	€2.48M
Amounts payable after one year	17	€721k
Amounts payable within one year	42/48	€1.75M
Trade debts payable within one year	44	€1.16M
Income statement
Turnover	70	€3.28M
Gross operating margin	9900	€1.30M
Operating result	9901	€44k
Financial income	75	€0
Financial charges	65	€44k
Result before taxes	9903	€716
Net result for the period	9904	€716
Result to be appropriated	9905	€716

Parcel (capakey)	Region	Area	Buildings	Height / fl.
55010D0046/00H000	Wallonia	239 m²	1 · 118 m²	-
92007F0104/00H002	Wallonia	229 m²	1 · 67 m²	13.8 m · 4 fl.

Summary